TMCI
Treace Medical·NASDAQ
--
--(--)
--
--(--)
3.71 / 10
Netural
Money flow analysis registers 7.41/10, showing robust fund flow characteristics. Positive momentum in Large is countered by negative tendencies in overall, block, Small, Medium, and Extra-large, suggesting positive flow conditions. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(100.0%) representing 1 analyst views, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-02
InstitutionLake Street
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for TMCI?
- TMCI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.71/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
